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Abstract
Background: The upper respiratory tract functions to protect lower respiratory structures from chemical and biological
agents in inspired air. Cellular oxidative stress leading to acute and chronic inflammation contributes to the resultant
pathology in many of these exposures and is typical of allergic disease, chronic sinusitis, pollutant exposure, and bacterial
and viral infections. Little is known about the effective means by which topical treatment of the nose can strengthen its
antioxidant and anti-inflammatory defenses. The present study was undertaken to determine if naturally-occurring plant
oils with reported antioxidant activity can provide mechanisms through which upper respiratory protection might occur.
Methods: Controlled exposure of the upper respiratory system to ozone and nasal biopsy were carried out in
healthy human subjects to assess mitigation of the ozone-induced inflammatory response and to assess gene
expression in the nasal mucosa induced by a mixture of five naturally-occurring antioxidant oils - aloe, coconut,
orange, peppermint and vitamin E. Cells of the BEAS-2B and NCI-H23 epithelial cell lines were used to investigate
the source and potential intracellular mechanisms of action responsible for oil-induced anti-inflammatory activity.
Results: Aerosolized pretreatment with the mixed oil preparation significantly attenuated ozone-induced nasal
inflammation. Although most oil components may reduce oxidant stress by undergoing reduction, orange oil was
demonstrated to have the ability to induce long-lasting gene expression of several antioxidant enzymes linked to
Nrf2, including HO-1, NQO1, GCLm and GCLc, and to mitigate the pro-inflammatory signaling of endotoxin in cell
culture systems. Nrf2 activation was demonstrated. Treatment with the aerosolized oil preparation increased
baseline levels of nasal mucosal HO-1 expression in 9 of 12 subjects.
Conclusions: These data indicate that selected oil-based antioxidant preparations can effectively reduce inflammation
associated with oxidant stress-related challenge to the nasal mucosa. The potential for some oils to activate intracellular
antioxidant pathways may provide a powerful mechanism through which effective and persistent cytoprotection
against airborne environmental exposures can be provided in the upper respiratory mucosa.
Background
Inflammation in the respiratory system related to tissue
oxidant stress is common to a wide variety of airborne
exposures and infections. Among well-described environ-
mental exposures are the oxidant pollutants, ozone and
nitrogen dioxide, ambient particulate matter, and cigarette
smoke [1-6]. Many acute and chronic inflammatory dis-
eases of the airways are also associated with oxidant stress
and include chronic obstructive pulmonary disease
(COPD), asthma, chronic sinusitis, viral and bacterial
infections, and idiopathic pulmonary fibrosis [7-14].
Studies support the concept that the upper respiratory
system plays an important protective role in many of
these types of challenges. In the case of chemical agents,
this is achieved by the capture and neutralization of for-
eign agents in the inspired airstream, limiting their
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impact on lower airway structures [15]. It has also been
demonstrated that the nose can serve as a repository for
inhaled viral and bacterial pathogens where they can be
eliminated or held in check by immune defenses,
thereby reducing the risk and/or severity of lower airway
infections [16-19].
Evidence indicates that inherent antioxidant and other
protective defenses in the tissues of the upper and lower
respiratory structures mitigate pulmonary inflammation
and that enhancement of these protective pathways can
reduce tissue damage, immune responses and morbidity
[20,21]. However, little is known about mechanisms
through which nasal antioxidant processes might be aug-
mented and, if so, to what extent such augmentation
would be effective as an intervention. As the primary cell
of interface between the internal and external environ-
ments, the mucosal epithelial cell has long been the focus
of much attention as a mediator of external stimuli and
facilitator of both innate and acquired immune defenses
in the respiratory tract [22,23]. Respiratory epithelial cells
are known to initiate the release of a cascade of proin-
flammatory mediators through redox signaling [8,24,25].
In addition, these cells have the capacity to exhibit up-
regulation of very effective antioxidant defense mechan-
isms involving the secretion of decoy oxidant targets, as
well as the synthesis of a broad spectrum of antioxidant
enzymes [26,27]. Agents with the ability to enhance anti-
oxidant pathways and interfere with proinflammatory sig-
naling in the upper respiratory epithelial mucosa could
enhance the protection afforded by these air passages.
The current studies were undertaken to determine if
natural oils with reported antioxidant activities might
represent a well-tolerated and potentially effective means
through which to enhance innate protective mechanisms
in the nose. For the purposes of this investigation, focus
was directed on a formulation containing five of these
oils - coconut, orange, aloe, peppermint and vitamin E -
for which the literature provides evidence of their direct
action as reducing agents, but does not address other
potential pathways of their antioxidant activity. In the
case of coconut oil, its phenolic acid constituents have
been proposed as the primary sources of its oxidant spe-
cies scavenging activity [28]. Various fractions of orange
oil have been shown to contain flavonoids and phenolic
acids, as well as constituent aldehydes, such as citronellal,
decanal, and terpine alcohol constituents, such as lina-
lool. These components have been demonstrated to exert
antioxidant activity through direct scavenging of hydroxyl
and other radicals [29,30]. A large number of phenolic
constituents are also found in oil derived from Aloe and
have been shown to be primarily responsible for its
superoxide and hydroxyl radical and hydrogen donating
capacity [31,32]. The phenolic constituents of oil derived
from peppermint leaves include fatty acids, and
flavonoids that are very efficient scavengers of oxidant
radicals, especially hydroxyl radical [33,34]. The well-
described antioxidant activity of vitamin E (tocopherol) is
primarily due to the capacity of its heterocyclic chroma-
nol ring to donate phenolic hydrogen to peroxyl radicals,
a key process in protecting the integrity of lipid mem-
branes [35]. Soy oil was used as a carrier oil because of
its reported high oxidative stability [36]. For these stu-
dies, the actions of a mixture of these oils administered
by aerosol spray were investigated in human subjects and
by direct application in human epithelial cell culture sys-
tems. The goals were (1) to investigate if preventive treat-
ment with the oil mixture could be demonstrated to
abrogate in vivo pathophysiologic responsiveness to a
controlled oxidant challenge in the nose and (2) to utilize
human epithelial cell culture to identify the presence of
unique antioxidant activity beyond the scavenging of
reactive oxidant species and investigate the mechanism
through which such protective effect might be mediated
within the cells of the airway epithelium.
Methods
Preparation of Test Compounds
The oil-based preparation used in the present study was
supplied by Global Life Technologies Corp (GLT) (Chevy
Chase, MD) and is a member of their Nozin® brand pro-
duct line. The study formulation contains the following
components: soy oil - 69.18%; coconut oil - 20.00%; orange
oil - 4.90%; aloe vera oil - 4.90%; peppermint oil - 0.75%;
vitamin E - 0.27%. All components of the test formulation
are USP-grade and have been individually evaluated and
identified by the FDA to fall under the Generally Recog-
nized as Safe classification. This formulation has been
demonstrated to be without irritating or inflammatory
effects in an in vivo mammalian mucosal test system in
studies carried out on behalf of GLT by North American
Science Associates, Inc., an independent FDA-approved
safety testing agency. The oil-based preparation was admi-
nistered as supplied in both in vivo and in vitro experi-
ments, as described below.
For the human nasal studies, sterile water without
additives, containing 0.75% peppermint oil as a scented
masking agent, was selected for use as the sham test
agent. Because saline, itself, has been reported to reduce
inflammatory cell number in the nose [37], water was
considered to represent an appropriate vehicle against
which to compare the oil-based preparation.
Subjects
This study was conducted as prescribed by the research
protocol reviewed and approved by the Institutional
Review Board of the Johns Hopkins Bloomberg School of
Public Health. The study employed a single blind cross-
over design, as described in the treatment and exposure
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protocol, below. Nine healthy adult men and women (22
to 40 years of age) were recruited into the ozone exposure
study after obtaining informed consent (Table 1). Subjects
were excluded if they had a history of chronic respiratory
disease, cardiovascular disease or upper respiratory infec-
tion during the previous four weeks, if they were “smo-
kers” or if they indicated an inability to sustain light
exercise for at least 30 min. “Non-smokers” were defined
as those individuals with a lifetime total of fewer than 3
pack-years plus abstinence from smoking of at least one
year prior to the study. Subjects were required to refrain
from taking prescription and non-prescription anti-inflam-
matory medications for the week prior to, and for the
duration of, the 3-week study period. One subject was
removed from the study after the initial nasal lavage indi-
cated the presence of very high numbers of leukocytes in
the nose (>100,000/ml), suggesting the presence of a latent
upper respiratory infection. A second subject withdrew
himself for reasons unrelated to the study.
Consistent with Institutional Review Board approval
and following the same exclusion and informed consent-
ing procedures described above, a second cohort of 12
different healthy adult subjects (9 men and 3 women)
22 to 62 years of age were recruited to assess the effects
of the oil preparation on baseline antioxidant gene
expression in the nasal epithelium (Table 2).
Cells
BEAS-2B Cells
Cells of the BEAS-2B human bronchial epithelial cell
line were obtained from the American Type Culture
Collection (ATCC, Bethesda, MD). Cultures were
expanded by growth on T-75 plastic flasks in DMEM/F-
12 (1:1) medium (Invitrogen, Grand Island, NY) and
seeded on 6- or 12-well Falcon filter inserts ( 0.4 μm
pore size; Becton Dickinson, Franklin Lakes, NJ) and
grown to confluence with the same medium above and
below prior to treatment.
H23 Cells
Cells of the NIH-H23 human lung cell line were pur-
chased from the American Type Culture Collection.
H23 cells were transfected with a plasmid vector (pGL3
vector with a minimal promoter) purchased from Pro-
mega Corporation, Madison, WI, expressing the firefly
luciferase gene driven by a minimal TATA-like promo-
ter. Upstream to the promoter, a short DNA fragment
containing the Nrf2 binding site found in the NQO1
gene promoter was cloned, as previously described in
BEAS-2B cells [38]. H23 cells expressing the reporter
plasmid were selected using blasticidin as the antibiotic.
Several clones were screened using the luciferase assay
and one clone exhibiting maximum luciferase activity
was selected for detailed characterization of its Nrf2
activation profile. Sulforaphane, a naturally-occurring
isothiocyanate known to activate Nrf2 [39] was used to
Table 1 Exposure of Healthy Subjects to Ozone
Change in Inflammatory Cell Counts*
Pre- to Post-Ozone




1 24 M 1099 -110
2 33 M 2503 -314
4 25 M 1825 34
5 30 F 666 -1209
6 27 M 70 -2581
7 22 M 701 -435
9 28 M 516 -361
Mean (SEM) 1054 (317) -711 (346)†
*Inflammatory cell counts expressed as number/ml lavage fluid returned.
†Significantly different from sham treatment (P < 0.001) by paired t analysis.
Table 2 Activation of Nrf2 by Components of the Natural
Oil Preparation
Component* Relative Luciferase Activity**
Mean SEM
Medium Control 7.0 0.6
Soy Oil Vehicle 7.5 0.5
Sulforaphane (100 um) 41.8† 1.3
Mixed Oil Preparation 40.8† 5.2
Coconut Oil (20%) 6.6 0.8
Orange Oil (5%) 52.5† 9.2
Aloe Oil (5%) 5.7 0.7
Peppermint Oil (0.75%) 5.7 0.9
Vitamin E (0.25%) 5.0 0.7
Mean values from 4 separate experiments in which duplicate cultures were
treated.
*Individual oil percentages represent v/v in soy oil: treatment duration = 15
min, except sulforaphane = 12 hr.
**Activation of Nrf2 expressed as relative luciferase luminescence per mg
cellular protein.
†Significantly increased above Medium Control value, P < 0.001, Mann-
Whitney Rank Sum Test.
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demonstrate that Nrf2 dependent luciferase reporter
activity in the H23-ARE-luciferase cells was dose-depen-
dent and linked to downstream antioxidant enzyme
gene activation [38]. These cells were cultured and
seeded on filter inserts, as described above, and used in
all assessments of Nrf2 activation in the present study.
Treatment and Exposure of Subjects to Ozone
The human subjects component of the study was car-
ried out in the Health Effects Assessment Laboratory
(HEAL) in the Department of Environmental Health
Sciences of the Bloomberg School of Public Health. The
purpose of this study was to test the hypothesis that oil
treatment would mitigate ozone-induced upper respira-
tory system neutrophil inflammation. A single blind,
non-randomized design was chosen to enable the identi-
fication and elimination from further unnecessary parti-
cipation any individuals who were unresponsive to this
level of ozone exposure. The masking scent in both
sham and test preparations kept subjects blinded to the
treatments in each arm. The study design is depicted in
Figure 1. On the first day of Arm 1 of the protocol, the
absence of baseline inflammation was confirmed in each
subject by determining that inflammatory cell concen-
trations fell within normal limits (<20,000 cells/ml nasal
lavage) (Figure 2). On the second day of Arm 1, the
aqueous control preparation containing 0.75% pepper-
mint oil as a masking agent was administered in a sin-
gle-blinded manner as a single 50 μl application in each
nostril using a metered spray applicator (model VP7/50
18/415 + poussoir 232 NA/B) manufactured by Aptar
(Le Vaudreuil, France). Immediately following nasal
treatment, subjects were exposed to 0.25 ppm O3 for
120 min. with alternating 30 min periods of rest and
light exercise consisting of slowly walking on a tread-
mill. Exposures took place in a temperature- and
humidity-controlled chamber as previously described
[40]. To optimize upper respiratory targeting, subjects
were visually monitored after being instructed to chew
gum with a closed mouth for the duration of the expo-
sure period. Eighteen hours following exposure, subjects
underwent nasal lavage to assess post-exposure. After a
7-10 day washout period, a second 3-day study period
was repeated in Arm 2 following the same procedures,
but associated with the nasal spray application of the
oil-based test agent.
Assessment of Nasal Inflammation
Nasal lavage was carried out according to a standardized
procedure. With the subject seated in a chair and the
head tilted backwards, 5 ml of 37°C Ringer’s lactate was
instilled by pipette into each nostril. After 5-10 seconds,
the head was brought forward and the fluid expelled
into a basin by gentle blowing. This procedure was
repeated 4 times. Following centrifugation, the cells
from all 4 tubes were pooled by re-suspension in phos-
phate buffered saline for cellular analysis.
Counts of inflammatory cells were made using a
hemocytometer and calculated as total inflammatory
cells per ml of nasal lavage return. Return volumes,
which averaged 84% of the 40 ml instilled volume, were
very consistent within each subject and were used to
normalize the inflammatory cell return. In healthy adults
without respiratory disease or allergic symptoms, ozone
exposure elicits a predominantly polymorphonuclear
neutrophilic (PMN) inflammatory response [41]. In the
present study, PMNs comprised greater than 95% of the
inflammatory cells recovered in nasal lavage fluid. Thus,
ARM TWOARM ONE
CONTROL PREPARATION TEST PREPARATION7 - 10 DAY
WASHOUTDAY 1 DAY 2 DAY 3 DAY 1 DAY 2 DAY 3
Spray Application;
Ozone Exposure
(2 hr; 0.25 ppm)
Spray Application;
Ozone Exposure







18 hr POST EXPOSURE
Questionnaire
Nasal Lavage
18 hr POST EXPOSURE
Questionnaire
Nasal Lavage
Figure 1 Depiction of the ozone exposure intervention protocol.
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the total number of leukocytes retrieved by lavage was
used as an index of nasal inflammation.
Cell-free supernatant from nasal lavage samples was
stored at -80°C prior to assay for the presence of the
inflammatory mediators IL-6 and IL-8 by ELISA (R & D
Systems, Minneapolis, MN).
Nasal symptoms prior to and at eighteen hours post
exposure in each of the two arms were scored following
a standard procedure [42,43] by having the subjects
make a mark on a horizontal 100 mm line indicating
the level of the symptom described, with the least sensa-
tion at the far left and the most at the far right. Scores
were determined by measuring the distance in mm from
the left end of the line and the change in numerical
values between the two arms were compared.
Assessment of Nasal Epithelial Gene Expression
Collection of nasal mucosal epithelial cells was made from
the upper and lower aspects of the inferior medial turbi-
nates of the right and left nostrils using a nasal mucosal
curette (Rhino-probe®). Epithelial biopsy samples were
taken prior to and 8 hours following administration of the
oil-based test agent or the scented control preparation
utilized in the ozone study. Using a metered spray applica-
tor, 50 microliters of each of the two agents was adminis-
tered in a single-blinded and random manner to one or
the other of the two nostrils. Using this design, each turbi-
nate provided its own baseline value for gene expression
and the two agents were tested simultaneously in the same
individual. Preliminary experiments in several subjects
demonstrated that prior sampling on the turbinate at a
site distant from the second sample site had no effect on
baseline expression of the heme oxygenase-1 (HO-1) target
gene in the second sample in the absence of treatment
(first to second expression ratio = 0.96 ± 0.06; mean ±
SEM, n = 8 sample pairs from 9 subjects). Biopsy samples
were frozen in liquid nitrogen and stored for RNA extrac-
tion and PCR analysis as described below.
Treatment of cells in culture
After ensuring that the surfaces of BEAS-2B epithelial
cell cultures were free of liquid, 200 μl of control agent
(HBSS or soy oil, as indicated) or test oil preparation
were added to the apical surfaces and evenly distributed
by rotation. It was found that the soy oil component of
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Figure 2 Intervention in oxidant pollutant exposure-induced inflammation at 18 hrs by topical application of the oil preparation.
Individual data showing the upper respiratory inflammatory responses of subjects exposed to ozone (0.25 ppm, 2 hr) when pretreated with 50
μl of scented sterile water (sham) or a mixture of natural oils administered by aerosol spray to each nostril. Each subject is represented by the
same symbol in both arms of the study; numbers correspond to subject numbers in Table 1. Points connected by dashed lines represent means
of each group. * indicates significant difference from baseline (P < 0.05) by paired t analysis.
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a negative control and, thus, soy oil was used in the
majority of cell culture studies as the control; ratio of
threshold cycle for HO-1 gene expression HBSS:soy =
1:1.01 ± 0.09 (±SD; n = 6). After treatment, the cultures
were returned to the incubator for 15 min. prior to
removal of the treatment fluids by suction. The surfaces
were then gently washed twice with 500 μl of warmed
(37°C) HBSS, and the cultures were returned to the
incubator for the designated periods of time prior to
extraction of RNA or protein. In two series of experi-
ments, control and oil-treated cells underwent further
challenge at 12 hours with lipopolysaccharide (LPS, 3
μg/ml medium, Escherichia coli, serotype 055.B5 -
Sigma.) for 4 hours prior to RNA extraction. The
removal of treatment oil by suction and the repeated
aqueous wash and removal of wash fluid and floating oil
by suction ensured the complete removal of oil from the
cultures prior to subsequent treatment. In the four sets
of experiments in which activation of Nrf2 by individual
treatment oil constituents and four sets in which the
dose-dependency of Nrf2 activation by orange oil was
assessed, duplicate cultures were extracted for measure-
ment of luciferase activity at the times indicated, as
described below.
Determination of Gene and Protein Expression
Real Time RT-PCR
Total RNA was extracted from cultured cells and from
nasal mucosal epithelial cells obtained by biopsy using
the RNeasy kit (Qiagen) and was quantified by UV absor-
bance spectrophotometry. The reverse transcription reac-
tion was performed by using the high capacity cDNA
synthesis kit (Applied Biosytems) in a final volume of
20 μl containing 1 μg of total RNA, 100 ng of random
hexamers, 1X reverse transcription buffer, 2.5 mM
MgCl2, 1 mM dNTP, 20 units of multiscribe reverse tran-
scriptase, and nuclease free water. Quantitative real time
RT-PCR analyses of Human heme oxygenase-1 (HO-1),
NAD(P)H:quinone oxidoreductase 1 (NQO1), glutamate
cysteine ligase-modulatory subunit (GCLm), glutamate
cysteine ligase-catalytic subunit (GCLc), and tumor
necrosis factor alpha (TNFa) were performed on cell and
nasal biopsy extracts using primers and probe sets from
Applied Biosystems. Assays were performed by using the
ABI 7000 Taqman system (Applied Biosystems). b-actin
was used for normalization.
Western Blot Analysis
To obtain total protein lysates, cells were lysed in RIPA
buffer containing Halt Protease Inhibitor cocktail (Pierce,
Rockford, Illinois, United States) and centrifuged at 12,000
g for 15 min at 4°C. Protein concentrations of the superna-
tant were measured using Bio-Rad protein assay (Bio-Rad,
CA). To detect the translocation of Nrf2 protein to the
nucleus, nuclear protein was isolated using the NE-PER
protein isolation kit (Pierce, Rockford, IL). For immuno-
blot analysis, 20 μg of total protein lysate or 20 μg of
nuclear protein lysate was resolved on 12% SDS-PAGE
gels. Proteins were transferred onto PVDF membranes
and blocked with PBS- Tween (0.1% Tween-20 in PBS, pH
7.2) supplemented with 5% low fat milk powder (w/v) for
2 hr at room temperature. All primary antibodies were
diluted in PBS-Tween (0.1%) with 5% nonfat dry milk and
incubated overnight at 4°C. Following antibodies were
used for immunoblotting: anti-HO1 (Abcam), anti-NQO1
(Novus Biologicals), anti-GCLm, and anti-GAPDH (Imge-
nex, Sorrento Valley, CA), anti-Nrf2 and anti-lamin B
(Santa Cruze Biotechnology (Santa Cruze, CA). After
washing the primary antibody, the membranes were incu-
bated with horseradish peroxidase conjugated anti-rabbit,
anti-mouse or anti-goat antibody (~1:2500 in 0.1% Tween-
20, with 5% low fat milk powder (w/v) for 1 hr at room
temperature. Membranes were again washed with PBS-
Tween (0.1%) and secondary antibodies were visualized
by enhanced chemiluminescence detection system (Amer-
sham Biosciences, NJ). Densitometric measurement of
individual target protein lots were normalized to GAPDH
or lamin B and quantified using the Image J (NIH) soft-
ware package for graphic display.
Determination of Nrf2 Activation
Changes in activation of the Nrf2 transcription factor in
cultured H23 ARE cells in response to treatment were
determined as previously described [44]. In brief, cells
grown to 70% confluence on 12-well inserts were trea-
ted as indicated for 15 min and incubated for 12 hr at
37°C. Rinsed cells were fully lysed and luciferase lumi-
nescence was generated using the E4030 Luciferase
Assay System (Promega) and detected with a TD-20/20
Luminometer (Turner Designs). Luminescence was nor-
malized to the protein content of each lysate as deter-
mined using the Bio-Rad Protein Assay System and
Microplate Reader. Nrf2 activation levels were expressed
as Relative Luminescence Units/ug protein.
Statistics
Nasal lavage and biopsy data were tested for differences
between control and oil-treatments using paired-t ana-
lyses. Comparisons of cell culture data were made using
Student’s t analyses. In instances of a lack of normality,
the Wilcoxon Signed Rank Test was used. In all cases, P
values < 0.05 were considered significant. Statistical ana-
lyses were carried out with SigmaStat Statistical software
(Jandel Scientific, San Rafael, CA).
Results
Ozone-induced nasal inflammation
In the majority of individuals, the typical response of expo-
sure of the upper and lower respiratory epithelium to
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ozone is inflammation and an influx of inflammatory cells,
especially PMNs, to mucosal and luminal regions. This
process is mediated by the oxidant stress-related release of
pro-inflammatory mediators, primarily IL-8, by epithelial
cells. As a means to determine if administration of the oil
preparation could afford protection against this example
of oxidant-induced inflammation in the upper respiratory
system, the effect of pretreatment with the oil was com-
pared to that of sham control. As assessed by nasal lavage,
controlled exposure to 0.25 ppm ozone for 2 hr resulted
in nominal to 9-fold increases in inflammatory cell
influx in seven subjects undergoing sham pretreatment
(Figure 2). Differential cell counts showed these cells to be
> 96% PMNs with occasional mononuclear and infrequent
eosinophilic cells. This increase in inflammatory response
was statistically significant within this treatment group. In
the same subjects undergoing pretreatment with the aero-
solized oil preparation, the ozone-induced increase in
inflammatory cells in the nasal lavage was completely
inhibited. Moreover, post-exposure cell numbers were sta-
tistically reduced below those present at baseline prior to
the exposure (Figure 2). This observation suggested that a
mechanism beyond simple blockade of ozone access to
the tissues or scavenging of ozone-derived reactive species,
perhaps involving direct reduction of inflammatory signal-
ing, was initiated in tissues undergoing oil treatment.
Comparison of the two treatment regimens based on pre-
to post-ozone changes in inflammatory cell counts
demonstrated that administration of the oil preparation
significantly reduced the pro-inflammatory response of the
subjects to ozone exposure (Table 1). Average lavage
return was not different in the two treatment arms (sham:
33.4 ml; oil: 33.7 ml).
ELISA determinations of Interleukins 6 and 8 indicated
that these inflammatory mediators were not detectable in
nasal lavage samples at 18 hr post ozone exposure. The
time of the nasal lavage was selected to coincide with
expected peak neutrophil presence in the nasal airspace
at 18 hours following the short, 2 hr exposure period. It
is likely that this time point was too late to detect the
presence of these early mediators in the nasal lavage.
Consistent with reduced levels of tissue inflammation as
assessed by cellular influx at 18 hr post-exposure, symp-
tom scores for “ease of airflow through the nose” at that
time were significantly greater in ozone-exposed subjects
following pretreatment with the oil preparation when
compared to sham treatment (P < 0.05). This was the only
nasal symptom measure to show significant change during
the study.
Inhibition of endotoxin-induced pro-inflammatory gene
expression by the oil preparation
In order to pursue the possibility that the reduction in
nasal inflammatory response to ozone exposure was not
due simply to a barrier effect of the oil preparation on
the nasal epithelial tissues, the anti-inflammatory effect
of oil treatment was tested in cultures of BEAS-2B cells
utilizing the bacterial endotoxin lipopolysaccharide
(LPS) rather than ozone to induce pro-inflammatory sig-
naling. Twelve hours following a 15 minute pretreat-
ment of cell cultures with HBSS (control) or the oil
preparation, cells were exposed to 3 μg/ml of LPS for 4
hours. At the end of the exposure period, real-time PCR
was used to assess gene expression of TNFa, an early
proinflammatory cytokine that is elevated during LPS-
induced inflammation. TNFa transcript levels were nor-
malized to those of actin. Two separate experiments
were performed, utilizing triplicate cultures per treat-
ment group; fold change data are presented as mean ±
SD. There was no difference in relative expression of
TNFa between control cells and those treated with the
oil-based preparation alone (control: 1.1 ± 0.54; oil: 0.51
± 0.19). In sham-pretreated cultures, LPS increased
expression of TNFa by 81-fold, compared to that in
unchallenged controls (80.6 ± 23.4). In contrast, in oil
pre-treated cells, the fold-change in proinflammatory
signaling induced by LPS exposure was reduced by
more than 50% (33.4 ± 3.6 fold compared to controls).
These data provided preliminary support of the notion
that one or more components of the oil preparation
may act by directly inducing antioxidant/anti-inflamma-
tory pathways within the respiratory epithelium.
Kinetics of antioxidant gene expression induced by the
oil preparation
To investigate the effects of the oil preparation on the
global system of antioxidant genes induced within the
respiratory epithelium by the Nrf2 transcription factor,
representative gene targets of Nrf2 were selected for
study. The kinetics of gene expression induced by 15
min of oil treatment were investigated in cells of the
BEAS-2B line following extraction at 3, 6, 12, and 24
hours after treatment. As seen in Figure 3, HO-1 exhib-
ited a 3.5-fold increase in expression at 3 hours that
reached more than 60-fold by 6 hours. After remaining
at a 20-fold level of elevation for up to 12 hours, HO-1
expression returned toward its time-matched control,
but remained elevated by more than 2-fold at 24 hours.
In contrast, neither NQO1 nor GCLc expression
increased by more than 2.0-fold until 12 hours post
treatment, when they increased 3.1- and 2.2-fold,
respectively. The increase in NQO1 expression above 2-
fold remained through 24 hrs. Expression of the modu-
latory sub-unit of GCL was likewise delayed relative to
HO-1, but remained at or above a 4-fold level of activa-
tion at 6 and 12 hours. These data provide evidence
that one or more constituents within the oil preparation
activate Nrf2.
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Activation of Nrf2 by components of the oil preparation
In order to identify the source of Nrf2 activation within
the oil preparation, constituent oils were individually
prepared in soy oil carrier in the same concentrations as
in the combined preparation. Medium and soy oil were
used as negative controls and the known Nrf2 activator,
sulforaphane, and the mixed oil preparation were used
as positive controls. With the exception of sulforaphane,
cultures of H23 reporter cells were treated for 15 min
with the test preparations, incubated, and assayed for
luciferase luminescence at 12 hr post-treatment, as
described in Methods. In all cell culture studies, the
water soluble Nrf2 activator, sulforaphane, dissolved in
cell culture medium was allowed to remain on the cul-
tures for the entire 12 hr incubation period prior to
assay. Preliminary experiments had shown that treat-
ment of the cells for the 15 min exposure period was
inadequate to cause significant activation of Nrf2 above
that seen in medium or soy-treated controls. In contrast,
12 hr treatment resulted in 5-fold higher activation
levels (15 min: 8.4 ± 1.5 RLA vs. 12 hr: 41.8 ± 1.7 RLA,
Mean + SD). The results of the screening of mixed oil
preparation components, presented in Table 2, indicate
that orange oil was the apparent single source of Nrf2
activation within the preparation of antioxidant natural
oils, inducing levels of activation comparable to those of
the original mixed oil preparation.
Nrf2 Activation by orange oil
The dose-related activation of Nrf2 by orange oil was
assessed in cultures of BEAS-2B cells. Cell cultures were
treated for 15 min with a range of concentrations of
orange oil in soy oil from 1% to 10% and assayed at 6
hr post treatment. Culture medium, soy oil and sulfora-
phane were used as controls. The data depicted in Fig-
ure 4 demonstrate a dose-response relationship with
reaching a maximum at 5%, with no further increase at
10%.
Assessment of cellular toxicity
Because cellular toxicity-related oxidant stress associated
with chemical exposures can initiate Nrf2 activation, a
series of experiments were undertaken to assess the
potential toxic effects of the orange oil. The release of
LDH by cells was used as a sensitive marker of toxicity.
BEAS-2B cells were treated as before with controls and
a range of orange oil concentrations from 1% to 20%
and assayed for total LDH release during the subsequent
6 hr period. The data presented in Figure 5 indicate no
measurable differences in LDH release in the range
from 1% to 10% compared to control treatments, sug-
gesting that the observed activation of Nrf2 in that dose
range was associated with activation mechanisms unre-
lated to cellular toxicity.
Translocation of Nrf2 to the nucleus
To provide further evidence that the effects of orange oil
treatment were Nrf2-associated, Western blot analysis
was used to determine translocation of Nrf2 protein to
the nucleus of BEAS-2B cells in 3 separate experiments,
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Figure 3 Treatment of cells with the mixed oil preparation
increases expression of oxidant-protective pathways with
differing activation kinetics. Time-courses of expression of
antioxidant genes HO-1, NQO1, GCLm, and GCLc in cells of the BEAS-
2B human bronchial epithelial line at designated times following
the 15 min treatment period. Data are presented as fold change
from time-matched soy oil controls after normalization to the
expression of actin. Presented are results from three separate
experiments. The dashed line indicates the 2-fold level of increased
expression as a reference for potential biological significance.
Results are expressed as mean ± SEM. * indicates significantly
different from time-matched soy oil controls (P < 0.05) by Student’s
t test.





















n = 8 cultures








Figure 4 Activation of Nrf2 by orange oil. Dose-related activation
of Nrf2 based on luciferase luminescence in cells containing the
ARE-luciferase reporter construct. Activity was assessed at 12 hr
following the 15 min treatment period. * indicates significantly
different from soy oil-treated control cultures (P < 0.05) by Student’s
t test.
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all of which showed similar results. Figure 6 shows repre-
sentative blots from of one of these experiments and
mean data from all three, which demonstrated a greater
than 4-fold increase in the presence of Nrf2 protein in
the nuclei of cells at 2 hr following treatment with 5%
orange oil in soy compared to soy oil-treated controls.
The nuclear protein lamin B was used to normalize pro-
tein loading. These data are consistent with the rapid
translocation of Nrf2 from the cytoplasm to the nucleus
following orange oil treatment.
Kinetics of orange oil-induced antioxidant gene
expression
In order to confirm that the representative Nrf2-regulated
antioxidant genes observed to be up-regulated following
treatment with the mixed oil preparation were similarly
activated by the orange oil alone, a set of experiments
identical to those shown in Figure 3 were carried out
using 5% orange oil in soy. The relative fold increase in
expression for each of the genes at 3, 6, 12 and 24 hr post-
treatment were compared to their corresponding time-
matched soy oil controls. As seen in Figure 7, the kinetics
and relative magnitudes of gene expression for each of the
four genes in response to orange oil treatment were simi-
lar to those seen in response to the mixed oil preparation.
Kinetics of orange oil-induced antioxidant protein
expression
As confirmation that increased gene expression trans-
lated to increased protein synthesis, the time-course of
increases in HO-1, NQO1 and GCLm was assessed at 6,
12 and 24 hr post-exposure to 5% orange oil by Western
blot analysis in three separate experiments. As shown
Figure 8, which provides representative blots from one of
these experiments and summary data from all three,
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Figure 5 Absence of LDH release in response to effective
concentrations of orange oil. LDH release from BEAS-2B cells used
as a measure of increased membrane permeability in response to
control and oil treatments. * indicates significantly different from
soy oil control cultures (P < 0.05) by Student’s t test.



































Figure 6 Rapid translocation of Nrf2 to the nucleus. Increase in
levels of Nrf2 in the nuclear protein fraction of cells observed at 2
hr following treatment with orange oil compared to buffer and soy
oil-treated controls. Representative blots from one of three separate
experiments are shown above. Mean Nrf2 blot densities normalized
to those of their corresponding nuclear lamin B for all three
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Figure 7 Kinetics of orange oil-induced antioxidant gene
expression. Expression patterns of antioxidant genes HO-1, NQO1,
GCLm, and GCLc in BEAS-2B cells at designated times following the
15 min treatment period. Data are presented as fold change from
time-matched soy oil-treated controls after normalization to the
expression of actin. Presented are results from two separate
experiments. The dashed line indicates the 2-fold level of increased
expression. Results are expressed as mean ± SEM. * indicates
significantly different from time-matched soy oil-treated controls (P
< 0.05) by Student’s t test.
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treated cultures were compared to time-matched soy
treated controls at each time point. Treatment and con-
trol blot densities were normalized to GAPDH and are
depicted below each pair of samples. Generally consistent
with its early gene expression in response to 5% orange
oil shown in Figure 7 and with the anticipated delay,
HO-1 showed a rapid 2-fold increase in protein that was
apparent by 6 hr and reached a greater than 4-fold level
of increase by 24 hr. In contrast, NQO1 protein expres-
sion was less rapid, exhibiting a 1.5-fold increase that was
not seen until 12 hr. GCLm showed a less pronounced
increase in enzyme protein of 1.3-fold at 24 hr that fol-
lowed its peak gene expression at 12 hr (Figure 7). These
data, along with those of orange oil-induced nuclear
translocation of Nrf2 and gene activation, offer strong
evidence for orange oil as an effective activator of Nrf2 in
respiratory epithelial cells.
Inhibition of endotoxin-induced pro-inflammatory gene
expression by orange oil
Following the same experimental procedure that had
shown mitigation of the LPS-induced gene expression of
the pro-inflammatory mediator, TNFa, by the mixed oil
preparation, two separate experiments were undertaken
to determine the extent to which this effect could be
attributed to the orange oil component. BEAS-2B cell
cultures were pretreated with 5% orange oil or with
HBSS as control for 15 min and incubated for 12 hr
prior to challenge with 3 ug/ml LPS. Cells were
extracted for PCR analysis after 4 hours of LPS chal-
lenge. As shown in Figure 9, LPS challenge increased
the expression of TNFa by approximately 50-fold in
HBSS pre-treated cultures and 30-fold in those pre-
treated with the orange oil. The significant 43% reduc-
tion in pro-inflammatory signaling produced by a single
15 minute treatment with orange oil 12 hours prior to
LPS challenge indicates the presence of a significant and
persistent modulatory effect of the oil on this inflamma-
tory process. It also provides additional evidence that
the presence of orange oil in the mixed oil preparation
contributed to its observed anti-inflammatory activity in
the nose.
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Figure 8 Antioxidant enzyme synthesis in response to orange oil treatment. Immunoblot analysis demonstrating expression of HO-1,
NQO1 and GCLm proteins at 6, 12 and 24 hrs following 15 min treatment of BEAS-2B cells with the oil preparation or time-matched soy oil
control. Representative blots from one of three separate experiments are shown above. Densitometric evaluations of each target protein blot
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Figure 9 Pretreatment with orange oil preparation attenuates
LPS-induced expression of TNFa. Cells pretreated with HBSS or
the orange oil in soy were challenged 12 hr later with LPS (3 ug/ml
medium) or were left unchallenged. At 4 hr after LPS challenge,
TNFa transcript levels were measured using real time RT-PCR. Data
are presented as fold change from time-matched HBSS-treated
controls after normalization to expression of actin. * indicates
significantly different from cells HBSS pretreated and LPS challenged
(P < 0.004) by Student’s t test.
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Nasal epithelial antioxidant gene expression in vivo
A study was carried out to determine if the up-regulation
of antioxidant protective mechanisms observed in human
respiratory epithelial cells in culture in response to oil
treatment could be demonstrated in the nasal mucosa.
We asked if the previously employed nasal aerosol spray
administration of the oil mixture could demonstrably
increase expression of the rapidly-responding HO-1 gene
in the nasal mucosa 8 hr later. After obtaining informed
consent, twelve healthy volunteers were recruited to par-
ticipate in a protocol that took paired mucosal biopsies
from both nares to allow subjects to act as their own con-
trols, Biopsies were taken from the inferior medial turbi-
nates of the right and left nasal passages prior to and
8 hours following oil treatment in the absence of ozone
exposure. In 9 of the 12 subjects, HO-1 expression in
mixed oil-treated turbinates increased by at least 1.5-fold
above sham control and, in 6, expression was increased
more than 2-fold at the 8 hour sampling time point
(Table 3). That is, in all but 3 of 12 subjects, expression
was detectably higher in oil-treated turbinates. Overall,
paired analysis of the change in fold expression between
sham-treated and oil-treated turbinates using the
Wilcoxon Signed Rank Test demonstrated a significant
difference (P < 0.03). There was a 2-fold median increase
in gene expression in oil-treated nares compared to
sham-treated nares across all subjects (Table 3). PCR
analysis did not detect increases in any of the other target
genes at this early time-point post-exposure. These data
indicate that application of the original oil preparation
containing orange oil has the ability to measurably
increase antioxidant HO-1 gene expression in the human
nasal mucosa and provides a potential mechanistic
link between the antioxidant-associated in vitro data and
the observation of decreased ozone-induced nasal
inflammation.
Discussion
The present study was designed to determine if naturally-
occurring oils with antioxidant properties could be utilized
to provide protection against proinflammatory challenges
to the upper respiratory tract. The mechanisms involved
with such protection would likely include their direct abil-
ity to scavenge ROS that arise as a consequence of toxi-
cant exposure in the nasal epithelial mucosa. In addition,
the presence of molecular constituents within these oils
could presumably have an effect on antioxidant gene
expression within mucosal cells, contributing further to
their innate defense against agents that induce inflamma-
tion through oxidant-related pathways.
Exposure to ozone has long been known to lead to an
inflammatory response in the upper and lower respiratory
tracts characterized by the influx of PMNs [4,41]. Under
conditions of controlled exposure of subjects to 0.25 ppm
ozone for 2 hours in the present study, this response was
observed in the upper respiratory tract. Pretreatment of
the nasal passages by aerosol spray with a natural oil pre-
paration inhibited the inflammatory response. Because of
the reactive target that the antioxidant oil mixture and the
soy oil carrier (diluent) might present to inhaled ozone or
its reactive products, some degree of protection could
have been provided by a simple “barrier” effect [45]. This
would likely be greatest at times early in the exposure per-
iod prior to a reduction in surface oil levels that might
Table 3 Nasal Epithelial HO-1 Gene Expression in Healthy Subjects
Fold Change from Baseline*
Subject# Age (Yrs) Gender Sham Spray Mixed Oil Spray Mixed Oil
Fold Change
From Sham**
1 33 M 0.247 2.732 11.08
2 62 M 0.297 1.283 4.32
3 31 M 0.758 0.620 0.82
4 34 F 2.099 15.348 7.31
5 41 M 0.330 4.532 13.73
6 24 F 1.040 0.285 0.27
7 60 M 0.432 0.914 2.11
8 27 M 0.859 0.245 0.29
9 31 M 1.778 3.387 1.90
10 42 M 0.651 1.079 1.66
11 41 F 1.181 3.249 2.75
12 33 M 0.829 1.580 1.91
Median 0.793 1.432† 2.01
*Data calculated as fold change after normalization to corresponding b-actin expression.
**Values less than 1.0 indicate a decrease.
†Significantly different from sham treatment (P = 0.027), Wilcoxon Signed Rank Test.
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result from nasal mucociliary clearance [46]. If this were
the sole mechanism involved, it might be expected that
administration of the oil would reduce or, at best, elimi-
nate the ozone-induced influx of inflammatory cells. How-
ever, the data demonstrated that PMN levels in the nasal
lumen at the 18 hour post-exposure time point were sig-
nificantly reduced below those observed at baseline in the
pre-exposure samples. This observation suggests that
proinflammatory signaling was abrogated in the nasal
mucosa by the treatment, possibly through mechanisms
involving increased intracellular antioxidant activity lead-
ing to reduced inflammatory drive. In addition, it indicates
that this activity persisted in the tissue, at least to the sam-
pling point 18 hours after the ozone exposure period.
Ozone has been shown to stimulate the influx of PMNs
into the airway lumen as early as 1 hr following exposure
[47] suggesting very rapid initiation of pro-inflammatory
signaling. In the present study, the effectiveness of the oil
in reducing inflammation following exposure to ozone
could have had several temporal components. In addition
to the likely ROS scavenger effect of the mixed oil pre-
paration previously described, pre-treatment of the nasal
mucosa prior to exposure could have stimulated early
activation of intracellular antioxidant pathways to
increase baseline cellular protection. Involvement of anti-
oxidant genes with varying kinetic profiles of activity
could provide both immediate and more prolonged anti-
oxidant capacity. The activity of such a mechanism
would be consistent with the observed early induction
of the rapidly-responding enzyme, HO-1. HO-1 gene
expression was increased by 3-fold in cultured cells
within 3 hours of oil treatment and was also found to be
elevated in the nasal epithelium of naïve subjects 8 hr fol-
lowing administration of the mixed oil preparation.
Furthermore, the demonstration of related antioxidant
genes with delayed expression kinetics in the cell culture
studies provides the mechanistic basis for a sustained
antioxidant effect.
The four antioxidant genes investigated in this study,
HO-1, NQO1, GCLc, and GCLm, are known to have a
common antioxidant response element (ARE) in their
promoters and are expressed in an Nrf2-dependent
manner. The basic leucine zipper (bZip) transcription
factor, Nrf2, acting via an antioxidant/electrophile
response element, regulates the global expression of a
family of antioxidant enzymes and functions to maintain
cellular redox homeostasis [48]. The present investiga-
tion of the mixed oil preparation demonstrated that the
Nrf2-associated gene and protein expression observed
was predominantly associated with the orange oil com-
ponent. Nrf2 activation by that oil was confirmed in a
battery of cell culture studies that demonstrated activa-
tion kinetics, dose-dependency, translocation of Nrf2
protein to the nucleus, and the gene and protein
expression of Nrf2-activated antioxidants. Although the
focus of the present study was directed toward the Nrf2
system, the possibility remains that other components of
the mixed oil preparation activated additional antioxi-
dant or anti-inflammatory-associated transcription fac-
tors that contributed to the observed reduction of nasal
mucosal inflammation.
Among the antioxidant genes studied, HO-1 induction
in response to oil treatment was the most rapid and dra-
matic. Heme oxygenase catalyzes the rate limiting steps of
heme oxidation to biliverdin, carbon monoxide and iron.
Biliverdin is rapidly converted to bilirubin, a potent endo-
genous antioxidant. Three isoforms of heme oxygenase
have been reported: the inducible HO-1 and the constitu-
tively expressed HO-2 and HO-3. An increasing number
of studies implicate HO-1 in the regulation of inflamma-
tion. The induction of HO-1 has been demonstrated in
many models of lung injury including hyperoxia, endotox-
emia, bleomycin, asthma, acute complement-dependent
lung inflammation, and heavy metals [49,50].
In an in vitro model of oxidative stress using pulmonary
epithelial cells stably transfected to over-express HO-1,
Lee et al. [51] demonstrated that these cells exhibited
increased resistance to hyperoxic cell injury. In studies by
Petrache et al. [52] and Soares et al. [53], HO-1 also pre-
vented TNF-a-mediated apoptosis in fibroblasts and
endothelial cells, respectively. Such findings further under-
score the importance of HO-1 in cytoprotection and the
potential prophylactic benefits of its up-regulation.
Otterbein and colleagues [54-56] have demonstrated
that HO-1 induction correlated with cytoprotection
against oxidative stress in vivo. Using hyperoxia as a
model of acute respiratory distress syndrome in rats, they
demonstrated that the exogenous administration of HO-1
by gene transfer could confer protection against oxidant-
induced tissue injury. Adenoviral gene transfer of HO-1
(Ad5-HO-1) into the lungs of rats resulted in increased
expression of HO-1 and, importantly, induced a marked
resistance to hyperoxic lung injury [56,57]. Rats treated
with Ad5-HO-1 showed reduced levels of hyperoxia-
induced pleural effusion, neutrophil alveolitis, and bronch-
oalveolar lavage protein leakage. Furthermore, rats
over-expressing HO-1 showed increased survivability in
the presence of hyperoxic stress versus those treated with
the vector control virus [56,57].
Another of the antioxidants observed to undergo up-
regulation was NQO1, an enzyme primarily expressed in
tissues requiring a high level of antioxidant protection,
such as the epithelial cells of the lung, breast, colon, and
vascular endothelium. Expression of NQO1, suggests that
this molecule may play a key role in establishing the anti-
oxidant capacity in these cells [58]. Oxidant pollutants,
including diesel exhaust particles, induce NQO1 expres-
sion which plays a role in mitigating pollutant-enhanced
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IgE responses [58,59]. Furthermore, over-expression
of phase II enzymes, including NQO1, inhibited IgE
production and supports the concept that chemical up-
regulation of these enzymes may represent a chemopre-
ventative strategy in airway allergic diseases [58,59].
Thus, the oil-induced inductions of NQO1 and related
antioxidants may have broader implications for protec-
tion of the respiratory mucosa, extending to pollutant-
related pro-allergenic effects in susceptible individuals.
Cellular antioxidant defenses can counter inflammation
by limiting the levels of ROS generated. Expression of
genes involved in glutathione biosynthesis (i.e. GCLc, and
GCLm) was significantly up-regulated in response to oil
pretreatment. Further, pretreatment of BEAS-2B cells with
the mixed oil preparation or orange oil alone was observed
to greatly suppressed TNFa activation in response to LPS
treatment. Lower levels of glutathione have been reported
to augment activation of the proinflammatory transcrip-
tion factor, NF-B [60], consistent with our previous
report of a protective role of glutathione peroxidase in
LPS-induced septic inflammation [61]. In addition, induc-
tion of HO-1 may exert anti-inflammatory functions
through the generation of carbon monoxide and has been
shown to inhibit the LPS-induced expression of proinflam-
matory cytokines [50].
The results of the present study indicate that the mix-
ture of natural oils was capable of reversing the nasal
inflammatory response to ozone exposure in healthy
human subjects in a manner that persisted for up to
18 hours. In human airway epithelial cells in culture, short
duration (15 min) treatment with the mixture resulted in
activation of Nrf2 and increases in the expression of sev-
eral representative antioxidant genes with both rapid
response and late activation profiles. The effectiveness of
the short treatment duration was surprising, given the sig-
nificantly longer period identified in our preliminary stu-
dies (12 hr) and utilized by others [62] (24 hr) to elicit
robust activation of Nrf2-dependent enzyme systems
using the water-soluble Nrf2 activator, sulforaphane. It
may be that the oil-based preparation allows for rapid
integration of the active component(s) into the cell mem-
brane which then acts as a repository for sustained release
into the cell. It will be of interest to determine if the pre-
sence of a lipid-based carrier plays a role in increasing the
duration of antioxidant pathway activation. Consistent
with the observed up-regulation of Nrf2-activated antioxi-
dant genes in cultured airway epithelial cells, treatment of
test subjects with the oil mixture by nasal spray induced
detectable increases in nasal mucosal HO-1 gene expres-
sion. Although the easiest of the genes to assess in vivo
due to its rapid- and high-responding profile, the increased
expression of this gene in vivo provides support for the
notion that the mechanism of action identified for the oil
in the cell culture studies is associated with the protection
observed in the nasal ozone intervention study.
Although seemingly unrelated in terms of their
sources and the nature of their interactions with the
respiratory system, many environmental challenges
share the development of cellular oxidative stress as a
common pathway for cell activation, inflammation and,
in some cases, cytotoxicity. Such challenges include
virus and bacterial infection [10,63], allergen challenge
[64], and exposure to common gaseous and particulate
air pollutants [65,66], tobacco smoke [67], and bacterial
endotoxin [68]. It is important to note that many of
these diverse exposures occur in combination and may
synergize to produce greatly amplified responses within
epithelial cells of the respiratory tract. For example, in a
study of human bronchial epithelial cells in culture, it
was observed that the consequences of oxidant stress
induced by the oxidant pollutants ozone or nitrogen
dioxide in combination with rhinovirus infection
resulted in release of the proinflammatory mediator, IL-
8, at levels as much as 2.5-fold greater than those pre-
dicted by the individual exposures [3]. Thus, targeting
oxidant-driven pathways leading to inflammatory
responses in the upper respiratory tract may offer a
means to provide cytoprotection against a range of
environmental challenges to those tissues. Such antioxi-
dant strategies may be especially beneficial in individuals
who have reduced or absent phase II enzyme activity, as
may result from certain genetic polymorphisms.
Furthermore, the unique mechanisms of action afforded
by natural oil-derived preparations may offer opportu-
nities to broaden therapeutic approaches for those indi-
viduals who are poorly responsive to current treatments.
Conclusions
The present study demonstrates that aerosol spray deliv-
ery of a mixture of natural oils described to have antiox-
idant properties was able to abrogate the inflammatory
response to the oxidant pollutant, ozone, in the nasal
passages of healthy subjects. This oil preparation stimu-
lated the expression of several Nrf2-regulated early and
late responding antioxidant genes in human respiratory
epithelial cells in culture. The most rapidly-responding
of these genes, HO-1, was determined to undergo
increased expression in the nasal tissues of subjects trea-
ted with the oil mixture. Nrf2 activation was confirmed
in cell culture experiments and was associated with the
orange oil component. In total, these novel data offer
evidence that selected oil-based agents may utilize
mechanisms beyond direct ROS scavenging, such as the
activation of intracellular antioxidant pathways, to
strengthen anti-inflammatory protection within the
nasal epithelial mucosa. The ability of oil pre-treatment
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to inhibit the pro-inflammatory action of subsequent
bacterial endotoxin exposure of human respiratory
epithelial cells suggests the potential usefulness of such
a preparation in mitigating a broader array of inflamma-
tory and cytotoxic exposures to the upper respiratory
system.
The upper respiratory epithelial mucosa, at the junc-
ture of the external and internal environments, plays a
key role in the success of adaptive responses to oxidant-
stress related challenges, such as those associated with
pollutant exposures, microbial infections and allergic
challenge. The identification of naturally-occurring,
well-tolerated and potent activators of cytoprotective
mechanisms within these cells, such as the oil prepara-
tion investigated here, will expand our ability to develop
new tools for preventive and therapeutic intervention at
this critical respiratory interface.
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